Yohann Cartigny

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Quantum Genomics, Innate Pharma. Active years: 2014-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yohann Cartigny. Retrieved from https://idiyas.com/inventor/yohann-cartigny

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 1)

% Patents Active = 66.7

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

Years Active: 2014-2016

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9340497 - Method for the preparation of (3S,3S') 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid) (2016-05-17),

2. 9187418 - Method for the preparation of (3S, 3S') 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid) (2015-11-17),

3. 8735624 - Polymorphic form of CHDMAPP, method of preparation thereof, and pharmaceutical composition comprising same (2014-05-27),

Title: Yohann Cartigny: Innovator in Pharmaceutical Chemistry

Introduction

Yohann Cartigny is a notable inventor based in Bois Guillaume, France. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on innovative methods for synthesizing complex chemical compounds.

Latest Patents

One of his latest patents is a method for the preparation of (3S,3S') 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid). This invention outlines a new approach to synthesize this compound in five steps from (S)-ethyl 2-(benzyloxycarbonylamino)-4-(neopentyloxysulfonyl)butanoate A. This method showcases his expertise in developing efficient synthetic pathways for pharmaceutical applications.

Career Highlights

Yohann has worked with prominent companies in the pharmaceutical industry, including Quantum Genomics and Innate Pharma. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Yohann has collaborated with talented professionals, including Fabrice Balavoine and Jonathan Madec. These partnerships have fostered a creative environment that encourages innovation and the advancement of scientific knowledge.

Conclusion

Yohann Cartigny is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and collaborations. His contributions continue to impact the field positively, showcasing the importance of innovation in science.

Profile summary based on public USPTO records.